InvestorsHub Logo
icon url

Reeves

10/14/16 2:09 PM

#32921 RE: doccjc #32920

I believe it's also one of our largest raises. Typically they've been about 5-6 million and supposedly we had enough cash on hand to get us thru q1 2017. It's possible we have a partner lined up for x-22, but we weren't offered friendly terms because we weren't contributing money into the phase 3 trials. If a pharma company knows we're struggling for a partner they may be willing to put up the money but then want 75%+ of the rights when it hits the market. IMO